Acucela

Press Releases

 

2013

2012

2011

2010

2009

2008

2007

2006

2004

2003

 

05/08/13 Acucela and Otsuka Pharmaceutical Announce Phase IIa Clinical Results of Emixustat Hydrochloride
              (ACU-4429) in Patients with Geographic Atrophy (GA) Associated with Dry Age-related Macular
              Degeneration (AMD) at ARVO 2013 Annual Meeting

04/24/13 Acucela Announces Initiation of Phase 2b/3 Clinical Trial of Emixustat Hydrochloride
               (formerly known as ACU-4429) in Subjects with Geographic Atrophy (GA) Associated with
               Dry Age-Related Macular Degeneration (AMD)

01/03/13 Acucela Appoints Hans Peter Pfleger, PhD as Vice President Commercial Operations
               & Strategic Marketing